1 / 62

Growth Hormone Therapy: Bridging the Gap Between Children and Adults

Disclosures and discussion of off label use . None. Adult and Pediatric Endocrinology. Height - 50%. Objectives . Identify the clinical indications for GH therapy in children and adults.Recognize which children are at risk for adult GHD and may benefit from GH therapy after achieving final adult he

sylvia
Download Presentation

Growth Hormone Therapy: Bridging the Gap Between Children and Adults

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Growth Hormone Therapy: Bridging the Gap Between Children and Adults

    2. Disclosures and discussion of off label use

    3. Objectives

    4. Case

    6. Laboratory Data

    7. Delayed bone age

    9. Indications for GH Therapy

    10. Indications for GH Therapy

    11. Indications for GH Therapy

    12. Causes of GHD

    13. Making the Diagnosis

    14. Growth Hormone Stimulation

    15. Growth Hormone Secretion

    16. Insulin Tolerance Test

    17. Growth Hormone Concentrations

    19. Questions

    20.

    21.

    22. Does GHD Persist?

    23.

    26. GHD Does Persist

    30. Endocrine Society

    31. Questions

    32. Adult GHD Syndrome

    34. Study Design

    35. Measured Parameters

    36. Results

    37. Results

    38. Results

    39. Results

    40. Limited Efficacy of GH during the Transition of GHD Patients from Adolescence to Adulthood

    41. Limited Efficacy

    43. Baseline

    44. Results

    45. Results

    46. Lower Fat Mass

    47. Increased Lean Mass

    49. Back to the patient

    50. Integrated Transitional Care

    51. Who?

    52. What?

    53. What?

    54. When?

    55. Where?

    56. Why?

    57. Potential Benefits

    58. Potential Harm

    60. Practical Approach

    61. Practical Approach

    62. Keys to Successful Transition

More Related